GeneDx Holdings Corp. Depreciation
GeneDx Holdings Corp. (WGS) reported Depreciation of $3.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-03
- GeneDx Holdings Corp. depreciation for the quarter ending 2026-06-30 was $3.10M, a 35.39% increase year-over-year.
- GeneDx Holdings Corp. depreciation for the quarter ending 2026-03-31 was $2.71M, a 24.54% increase year-over-year.
- GeneDx Holdings Corp. depreciation for the quarter ending 2025-06-30 was $2.29M.
- GeneDx Holdings Corp. depreciation for the quarter ending 2025-03-31 was $2.17M.
- GeneDx Holdings Corp. depreciation for fiscal 2025 was $9.61M, a 21.15% increase from fiscal 2024.
- GeneDx Holdings Corp. depreciation for fiscal 2024 was $7.93M, a 59.77% decline from fiscal 2023.
- GeneDx Holdings Corp. depreciation for fiscal 2023 was $19.71M, a 60.55% decline from fiscal 2022.
- GeneDx Holdings Corp. depreciation for fiscal 2022 was $49.96M, a 129.10% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 12 month |
|---|---|---|---|
| 2026-06-30 | $3.10M 10-Q · filed 2026-08-03 | $5.80M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $2.71M 10-Q · filed 2026-05-04 | ||
| 2025-12-31 | $9.61M 10-K · filed 2026-02-23 | ||
| 2025-06-30 | $2.29M 10-Q · filed 2026-08-03 | $4.46M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $2.17M 10-Q · filed 2026-05-04 | ||
| 2024-12-31 | $7.93M 10-K · filed 2026-02-23 | ||
| 2023-12-31 | $19.71M 10-K · filed 2026-02-23 | ||
| 2022-12-31 | $49.96M 10-K · filed 2024-02-23 | ||
| 2021-12-31 | $21.81M 10-K · filed 2023-03-16 | ||
| 2020-12-31 | $11.73M 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |